Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions label was standardized to 'Intervention/Treatment' while removing the older 'Intervention / Treatment' phrasing. The page now indicates 'No longer looking for participants' for closed enrollment and the revision note was updated to v3.6.0, replacing v3.5.5.SummaryDifference0.4%

- Check11 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the study page, signaling a platform/content rendering update to the record. This does not modify study details or outcomes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the page. The change represents a revision of the page version rather than modifications to the study data.SummaryDifference0.1%

- Check40 days agoChange DetectedA new publication citation by Fountzilas et al. is added to the study's publications with full bibliographic details, replacing the previous online-ahead-of-print entry.SummaryDifference0.1%

- Check47 days agoChange DetectedNo additions or deletions are present. The content appears unchanged relative to the captured data.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a new site release. No changes to the underlying study content are reflected.SummaryDifference0.1%

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.